Cargando…

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy

Detalles Bibliográficos
Autores principales:	Peterson, Danielle M., Vesely, Matthew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935686/ https://www.ncbi.nlm.nih.gov/pubmed/33728367 http://dx.doi.org/10.1016/j.jdcr.2021.01.020

Ejemplares similares

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
por: Zubek, Amanda E., et al.
Publicado: (2020)

Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab
por: Smogorzewski, Jan, et al.
Publicado: (2019)

Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitis
por: Vesely, Matthew D., et al.
Publicado: (2016)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

Efficacy and safety of dupilumab in two adolescents with severe atopic dermatitis
por: Giavina-Bianchi, Mara, et al.
Publicado: (2021)

Treatment of Severe Atopic Dermatitis with Dupilumab in Patients with Advanced Cancer
por: Tanczosova, Milena, et al.
Publicado: (2023)

Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
por: MIYAMOTO, Shoko, et al.
Publicado: (2022)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
por: Shahriari, Neda, et al.
Publicado: (2023)

Improvement of atopic dermatitis and alopecia universalis with dupilumab
por: Alotaibi, Lama, et al.
Publicado: (2021)

Atopic dermatitis: Tofacitinib, an option for refractory disease
por: Berbert Ferreira, Sineida, et al.
Publicado: (2020)

Treatment of Severe Atopic Dermatitis with Dupilumab in Three Patients with Renal Diseases
por: Foti, Caterina, et al.
Publicado: (2022)

Dupilumab for atopic dermatitis
Publicado: (2019)

Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
por: Giavina-Bianchi, Mara Huffenbaecher, et al.
Publicado: (2019)

The use of dupilumab in severe atopic dermatitis during pregnancy: a case report
por: Akhtar, Nabeel H., et al.
Publicado: (2022)

Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
por: Maudinet, Adrien, et al.
Publicado: (2019)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
por: Esposito, Maria, et al.
Publicado: (2022)

Treatment of lichen sclerosus and hypertrophic scars with dupilumab
por: Peterson, Danielle M., et al.
Publicado: (2022)

Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
por: Call, John E., et al.
Publicado: (2020)

Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report
por: Mian, Madeeha, et al.
Publicado: (2020)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
por: Shan, Jinpeng, et al.
Publicado: (2022)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis()()
por: Chello, Camilla, et al.
Publicado: (2021)

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
por: Park, Jonathan J., et al.
Publicado: (2023)

Psoriasis appearing after dupilumab therapy in atopic dermatitis: A case report
por: Kim, Ho Seung, et al.
Publicado: (2020)

Treatment efficacy of dupilumab in a hyper-immunoglobulin E syndrome patient with severe atopic dermatitis
por: Su, Chia-Jui, et al.
Publicado: (2021)

Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis
por: Nettis, Eustachio, et al.
Publicado: (2021)

Remarkable response to dupilumab in a 5-year-old patient with severe, recalcitrant atopic dermatitis
por: Johnson, Brian B., et al.
Publicado: (2019)

Dupilumab for treatment of severe atopic dermatitis accompanied by lichenoid amyloidosis in adults: Two case reports
por: Zhao, Xue-Qi, et al.
Publicado: (2023)

Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
por: Alniemi, Dema T., et al.
Publicado: (2019)

Corneal ulceration associated with dupilumab use in a patient with atopic dermatitis
por: Li, Gavin, et al.
Publicado: (2020)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
por: Ayasse, Marissa, et al.
Publicado: (2020)

Successful Treatment of an Adult with Atopic Dermatitis and Lamellar Ichthyosis Using Dupilumab
por: Binkhonain, Faisal K, et al.
Publicado: (2022)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021)

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021)

Recalcitrant erythrodermic ichthyosis with atopic dermatitis successfully treated with Dupilumab in combination with Guselkumab
por: Steinhoff, M., et al.
Publicado: (2021)

Dupilumab therapy following JAK inhibitor withdrawal in moderate–severe atopic dermatitis
por: Kiely, Lisa, et al.
Publicado: (2022)

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023)

Clinical remission of disseminated molluscum contagiosum infection in a patient with atopic dermatitis treated with dupilumab()
por: Elosua-González, Marta, et al.
Publicado: (2022)

Relapsing-remitting multiple sclerosis arising in a patient with atopic dermatitis on dupilumab
por: Laageide, Leah, et al.
Publicado: (2021)

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
por: Igelman, Sean J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ad24jr2t4o727hv45hcoh9kc1j